Cargando…

Clinical Course and Treatment Implications of Combination Immune Checkpoint Inhibitor-Mediated Hepatitis: A Multicentre Cohort

BACKGROUND: Immune-related adverse events can occur after treatment with immune checkpoint inhibitors (ICI), limiting treatment persistence. We aimed to evaluate the clinical course of ICI-mediated hepatitis (IMH) associated with combination ipilimumab and nivolumab treatment. METHODS: A retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Matthew K, Chan, Yin, Suo, Aleksi E, Shaheen, Abdel Aziz, Congly, Stephen E, Tandon, Puneeta, Bhanji, Rahima A, Wells, Malcolm M, Cheng, Tina, Ma, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806044/ https://www.ncbi.nlm.nih.gov/pubmed/35118226 http://dx.doi.org/10.1093/jcag/gwab019

Ejemplares similares

Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting
por: Congly, Stephen E., et al.
Publicado: (2021)

Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
por: Riazi, Kiarash, et al.
Publicado: (2022)

Learning from a rare phenomenon — spontaneous clearance of chronic hepatitis C virus post-liver transplant: A case report
por: Singh, Noreen, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada
por: Shaheen, Abdel Aziz, et al.
Publicado: (2022)

Tu1261: IMPACT OF THE COVID-19 PANDEMIC ON THE EPIDEMIOLOGY OF ALCOHOL-ASSOCIATED HEPATITIS
por: Frolkis, Alexandra, et al.
Publicado: (2022)

Increased hospital admissions for alcohol-associated hepatitis during the COVID-19 pandemic in Alberta, Canada: a retrospective cohort study
por: Frolkis, Alexandra, et al.
Publicado: (2022)

Chronic hepatitis E: an important entity for clinicians to be aware of
por: Congly, Stephen E., et al.
Publicado: (2022)

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B
por: Sachar, Yashasavi, et al.
Publicado: (2021)

Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies
por: Ebadi, Maryam, et al.
Publicado: (2021)

Sarcopenia in cirrhosis: from pathogenesis to interventions
por: Ebadi, Maryam, et al.
Publicado: (2019)

Reliable Measures of Sarcopenia in Cirrhosis. Comment on: “The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097”
por: Ebadi, Maryam, et al.
Publicado: (2020)

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
por: Tandon, Puneeta, et al.
Publicado: (2009)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors
por: Meyers, Daniel E., et al.
Publicado: (2019)

The cirrhosis care Alberta (CCAB) protocol: implementing an evidence-based best practice order set for the management of liver cirrhosis - a hybrid type I effectiveness-implementation trial
por: Carbonneau, Michelle, et al.
Publicado: (2020)

Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2017)

Nutrition in Liver Cirrhosis and Transplantation—Current State and Knowledge Gaps
por: Raman, Maitreyi, et al.
Publicado: (2020)

A202 IMPACT OF THE COVID-19 PANDEMIC ON THE EPIDEMIOLOGY OF ALCOHOL-RELATED HEPATITIS
por: Frolkis, A, et al.
Publicado: (2022)

Development of a Theoretically Informed Web-Based Mind-Body Wellness Intervention for Patients With Primary Biliary Cholangitis: Formative Study
por: Watt, Makayla, et al.
Publicado: (2021)

Sarcopenia Severity Based on Computed Tomography Image Analysis in Patients with Cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2020)

Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
por: Stukalin, Igor, et al.
Publicado: (2023)

Eliciting and Understanding Primary Care and Specialist Mental Models of Cirrhosis Care: A Cognitive Task Analysis Study
por: Barber, Tanya, et al.
Publicado: (2021)

Multicentric reticulohistiocytosis in the course of undifferentiated connective tissue disease
por: Niklas, Karolina, et al.
Publicado: (2019)

Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders
por: Andrews, Christopher N, et al.
Publicado: (2019)

Indirect Calorimetry Performance Using a Handheld Device Compared to the Metabolic Cart in Outpatients with Cirrhosis
por: Schock, Lauren, et al.
Publicado: (2019)

Faculty Development Approaches for Life Support Courses: A Scoping Review
por: Ko, Ying‐Chih, et al.
Publicado: (2022)

Pathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor–Induced Kidney Injury
por: Abudayyeh, Ala, et al.
Publicado: (2022)

The Transcriptomic Response of Rat Hepatic Stellate Cells to Endotoxin: Implications for Hepatic Inflammation and Immune Regulation
por: Harvey, Stephen A. K., et al.
Publicado: (2013)

The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in Mice
por: Almishri, Wagdi, et al.
Publicado: (2019)

The checkpoint of death
por: Wells, William A.
Publicado: (2003)

Nutrition Center of Excellence (COE) in Inflammatory Bowel Disease—A Model and Rationale for Development
por: Shommu, Nusrat S, et al.
Publicado: (2019)

Real-world analyses of therapy discontinuation of checkpoint inhibitors in metastatic melanoma patients
por: Machado, Marina Amaral de Ávila, et al.
Publicado: (2020)

Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective study
por: Daoussis, Dimitrios, et al.
Publicado: (2020)

Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort
por: Hountondji, Lina, et al.
Publicado: (2023)

Patient Views on Advance Care Planning in Cirrhosis: A Qualitative Analysis
por: Carbonneau, Michelle, et al.
Publicado: (2018)

Feasibility of a tailored and virtually supported home exercise program for people with multiple myeloma using a novel eHealth application
por: Purdy, Graeme M., et al.
Publicado: (2022)

Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis
por: Fredrick, Thomas W, et al.
Publicado: (2022)

Rapid onsite evaluation in cytomorphology of Hydatidosis: A useful adjunct to diagnosis
por: Tummidi, Santosh, et al.
Publicado: (2022)

The Role of RBC Oxidative Stress in Sickle Cell Disease: From the Molecular Basis to Pathologic Implications
por: Wang, Qinhong, et al.
Publicado: (2021)

Impact of Implementing a “FIB‐4 First” Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
por: Davyduke, Tracy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kl3dpigk6m9acfp3c87sddvofh